المؤلفون: G Palmieri, F Consoli, M Valente, Corrado Caracò, Paolo Antonio Ascierto, Michele Maio, M Guida, G Rinaldi, Angelo Paolo Dei Tos, R Berardi, Giovanni Grignani, Paola Queirolo, Francesca Spada, Nicola Fazio, A Córdova, L Repetto, B Vincenzi, D Massi, G Fabbrocini, A Berruti, L Tagliaferri, P Rubegni, P Poletti, M Barberis, F Picciotto, Paolo Bossi, M Gatti, Vanna Chiarion Sileni, Pietro Quaglino, GC Antonini Cappellini, L Antonuzzo, G Badalamenti, F Bassetto, A Bongiovanni, P Bonomo, L Borgognoni, V Borzillo, F Bruder, D Campana, R Depenni, AM Di Giacomo, MC Fargnoli, V Ferraresi, F Ferrau, MT Fierro, F Gelsomino, D Giuffrida, P Graziano, C Gregorelli, R Mazzarotto, L Milesi, AM Minisini, F Morgese, P Muto, R Patuzzo, G Pellacani, J Pigozzo, N Pimpinelli, G Rubino, F Spagnolo, E Tanda, MC Tronconi, M Tucci, I Zalaudek

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/10/6/e004742.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/803650a72e7f4b7aa71f13ef3550f03b

المؤلفون: Chiloiro S; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Giampietro A; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Bianchi A; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Menotti S; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Angelini F; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Tartaglione T; Dipartimento di Radiodiagnostica, Istituto Dermopatico dell'Immacolata IDI IRCCS, 00168 Rome, Italy., Antonini Cappellini GC; UOC Oncologia, Ospedale Sandro Pertini, 00138 Rome, Italy., De Galitiis F; UOC Oncologia, Istituto Dermopatico dell'Immacolata IDI IRCCS, 00185 Rome, Italy., Rossi E; UOC Oncologia, Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy., Schinzari G; UOC Oncologia, Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy., Scoppola A; UOSD Endocrinologia, Ospedale Santo Spirito, 00193 Rome, Italy., Pontecorvi A; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., De Marinis L; Pituitary Unit, Department of Endocrinology and Metabolism, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00186 Rome, Italy., Fleseriu M; Departments of Medicine (Division of Endocrinology, Diabetes and Clinical Nutrition) and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, OR 97232, USA.

المصدر: Journal of personalized medicine [J Pers Med] 2023 Feb 26; Vol. 13 (3). Date of Electronic Publication: 2023 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE

المؤلفون: Levati L; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Bassi C; Department of Translational Medicine, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy.; LTTA Center, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy., Mastroeni S; Clinical Epidemiology Unit, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Lupini L; Department of Translational Medicine, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy., Antonini Cappellini GC; Department of Oncology and Dermatological Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Bonmassar L; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Alvino E; Institute of Translational Pharmacology, National Council of Research, Via Fosso del Cavaliere 100, 00133 Rome, Italy., Caporali S; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Lacal PM; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Narducci MG; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Molineris I; Department of Life Science and System Biology, University of Turin, Via Accademia Albertina 13, 10123 Turin, Italy., De Galitiis F; Department of Oncology and Dermatological Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., Negrini M; Department of Translational Medicine, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy.; LTTA Center, University of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy., Russo G; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy., D'Atri S; Laboratory of Molecular Oncology, IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy.

المصدر: Cancers [Cancers (Basel)] 2022 Jul 29; Vol. 14 (15). Date of Electronic Publication: 2022 Jul 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

عنوان ترانسليتريتد: Gestione del paziente con microcitoma nelle regioni Lazio, Umbria e Sardegna.

المؤلفون: Minuti G; Unità di Oncologia Medica 2, Istituto Nazionale Tumori Regina Elena, Roma., Stefani A; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Roma., Carpano S; Unità di Oncologia Medica 2, Istituto Nazionale Tumori Regina Elena, Roma., D'Argento E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Roma., Giusti R; UOC Oncologia, AOU Sant'Andrea, Roma., Martelli O; Divisione di Oncologia, ASL Frosinone., Metro G; Dipartimento di Oncologia Medica, Ospedale Santa Maria Della Misericordia, AO Perugia., Gelibter AJ; UOC Oncologia Medica 'B', Policlinico Umberto I, Sapienza Università di Roma., Antonini Cappellini GC; UOC Oncologia Interpresidio, Ospedale Sandro Pertini, ASL Roma2., Carta A; SC Oncologia Medica, Ospedale Businco - ARNAS G. Brotzu, Cagliari., Fadda GM; UOC Oncologia Medica, AO Universitaria di Sassari., Nelli F; UOC Oncologia, AO Belcolle, Viterbo., Ricciardi S; UOSD Pneumologia Oncologica, AO San Camillo Forlanini, Roma., Russano M; UOC Oncologia Medica, Policlinico Universitario Campus Bio-Medico, Roma., Bria E, Cappuzzo F

المصدر: Recenti progressi in medicina [Recenti Prog Med] 2021 Oct; Vol. 112 (10), pp. 639-646.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 0401271 Publication Model: Print Cited Medium: Internet ISSN: 2038-1840 (Electronic) Linking ISSN: 00341193 NLM ISO Abbreviation: Recenti Prog Med Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Small Cell Lung Carcinoma*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/therapeutic use ; Etoposide ; Humans ; Italy

المؤلفون: Cesati M; Department of Civil Engineering and Computer Science Engineering, University of Rome Tor Vergata, 00133 Rome, Italy., Scatozza F; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., D'Arcangelo D; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Antonini-Cappellini GC; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Rossi S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy., Tabolacci C; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy., Nudo M; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Palese E; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Lembo L; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Di Lella G; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy., Facchiano F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy., Facchiano A; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy.

المصدر: Cancers [Cancers (Basel)] 2020 Dec 08; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Narducci MG; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Tosi A; Department of Surgery, Oncology and Gastroenterology, Oncology and Immunology Section, University of Padua, Padua, Italy., Frezzolini A; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Scala E; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Passarelli F; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Bonmassar L; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Monopoli A; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Accetturi MP; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Cantonetti M; Department of Hematology, University of Rome Tor Vergata, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Rosato A; Department of Surgery, Oncology and Gastroenterology, Oncology and Immunology Section, University of Padua, Padua, Italy.; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Picozza M; Laboratory of Neuroimmunology, IRCCS Fondazione Santa Lucia, Rome, Italy., Russo G; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., D'Atri S; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

المصدر: Frontiers in immunology [Front Immunol] 2020 Sep 25; Vol. 11, pp. 579894. Date of Electronic Publication: 2020 Sep 25 (Print Publication: 2020).

نوع المنشور: Case Reports; Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , CD4-Positive T-Lymphocytes/*immunology , CD8-Positive T-Lymphocytes/*immunology , Killer Cells, Natural/*immunology , Lymphoma, T-Cell/*drug therapy , Melanoma/*drug therapy , Neoplastic Cells, Circulating/*pathology , Nivolumab/*therapeutic use , Sezary Syndrome/*drug therapy , Skin Neoplasms/*drug therapy, Aged ; Biomarkers, Tumor ; Female ; Humans ; Lymphoma, T-Cell/complications ; Male ; Melanoma/complications ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Sezary Syndrome/complications ; Skin Neoplasms/complications ; Tumor Burden

المؤلفون: Caporali S; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy., Amaro A; Molecular Pathology, IRCCS-Ospedale Policlinico San Martino, Genoa, Italy., Levati L; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy., Alvino E; Institute of Translational Pharmacology, National Council of Research, Rome, Italy., Lacal PM; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy., Mastroeni S; Clinical Epidemiology Unit, IDI-IRCCS, Rome, Italy., Ruffini F; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy., Bonmassar L; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy., Antonini Cappellini GC; Department of Oncology and Dermatological Oncology, IDI-IRCCS, Rome, Italy., Felli N; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Carè A; Center of Gender Medicine, Istituto Superiore di Sanità, Rome, Italy., Pfeffer U; Molecular Pathology, IRCCS-Ospedale Policlinico San Martino, Genoa, Italy., D'Atri S; Laboratory of Molecular Oncology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via dei Monti di Creta 104, 00167, Rome, Italy. s.datri@idi.it.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 Jun 21; Vol. 38 (1), pp. 272. Date of Electronic Publication: 2019 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Neoplasm*, ADAM Proteins/*genetics , Melanoma/*genetics , Membrane Proteins/*genetics , MicroRNAs/*genetics , Vascular Endothelial Growth Factor A/*blood, Adult ; Aged ; Aged, 80 and over ; Cell Line, Tumor ; Cell Proliferation ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Imidazoles ; Male ; Melanoma/blood ; Melanoma/drug therapy ; Middle Aged ; Mutation ; Oximes ; Proto-Oncogene Proteins B-raf/genetics ; Up-Regulation ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Cortellini A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy alessiocortellini@gmail.com.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Buti S; Medical Oncology, University Hospital of Parma, Parma, Italy., Santini D; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Perrone F; Medical Oncology, University Hospital of Parma, Parma, Italy., Giusti R; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Tiseo M; Medical Oncology, University Hospital of Parma, Parma, Italy., Bersanelli M; Medical Oncology, University Hospital of Parma, Parma, Italy., Michiara M; Medical Oncology, University Hospital of Parma, Parma, Italy., Grassadonia A; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy., Brocco D; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy., Tinari N; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy., De Tursi M; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Veltri E; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Marconcini R; Department of Oncology, University Hospital of Pisa, Istituto Toscano Tumori, Pisa, Italy., Malorgio F; Medical Oncology, 'Santo Spirito' Hospital, Pescara, Italy., Garufi C; Medical Oncology, 'Santo Spirito' Hospital, Pescara, Italy., Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Anesi C; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Zeppola T; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Filetti M; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Marchetti P; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Botticelli A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Vitale MG; Medical Oncology, University Hospital of Modena, Modena, Italy., Sabbatini R; Medical Oncology, University Hospital of Modena, Modena, Italy., Bracarda S; Medical Oncology, 'Santa Maria' Hospital, Terni, Italy., Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Rinaldi S; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Tudini M; Medical Oncology, AV2 Fabriano ASUR Marche, Fabriano, Italy., Silva RR; Medical Oncology, AV2 Fabriano ASUR Marche, Fabriano, Italy., Pireddu A; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy., Atzori F; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy., Chiari R; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Ricciuti B; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Iacono D; Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy., Migliorino MR; Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy., Rossi A; Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy., Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Cannita K; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Ciciarelli V; Dermatology, San Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Fargnoli MC; Dermatology, San Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy., Ficorella C; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

المصدر: The oncologist [Oncologist] 2019 Jun; Vol. 24 (6), pp. e327-e337. Date of Electronic Publication: 2019 Feb 22.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*adverse effects , Autoimmune Diseases/*immunology , Drug-Related Side Effects and Adverse Reactions/*epidemiology , Neoplasms/*drug therapy , Programmed Cell Death 1 Receptor/*antagonists & inhibitors, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Autoimmune Diseases/complications ; Autoimmune Diseases/mortality ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/immunology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasms/complications ; Neoplasms/immunology ; Neoplasms/mortality ; Programmed Cell Death 1 Receptor/immunology ; Progression-Free Survival ; Retrospective Studies ; Severity of Illness Index ; Young Adult

المؤلفون: Cortellini A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy. alessiocortellini@gmail.com.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. alessiocortellini@gmail.com.; Medical Oncology Unit, St. Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy. alessiocortellini@gmail.com., Bersanelli M; Medical Oncology, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Buti S; Medical Oncology, University Hospital of Parma, Parma, Italy., Cannita K; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Santini D; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Perrone F; Medical Oncology, University Hospital of Parma, Parma, Italy., Giusti R; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Tiseo M; Medical Oncology, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Michiara M; Medical Oncology, University Hospital of Parma, Parma, Italy., Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy., Tinari N; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Italy., De Tursi M; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Italy., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Veltri E; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Marconcini R; Department of Oncology, University Hospital of Pisa, Istituto Toscano Tumori, Pisa, Italy., Malorgio F; Medical Oncology, 'Santo Spirito' Hospital, Pescara, Italy., Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Anesi C; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Zeppola T; Medical Oncology, Campus Bio-Medico University, Rome, Italy., Filetti M; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Marchetti P; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Botticelli A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy., Vitale MG; Medical Oncology, University Hospital of Modena, Modena, Italy., Rastelli F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy., Pergolesi F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy., Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Rinaldi S; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Tudini M; Medical Oncology, AV2 Fabriano ASUR Marche, Pescara, Italy., Silva RR; Medical Oncology, AV2 Fabriano ASUR Marche, Pescara, Italy., Pireddu A; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy., Atzori F; Medical Oncology Unit, University Hospital of Cagliari, Cagliari, Italy., Chiari R; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Ricciuti B; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., De Giglio A; Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Iacono D; Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, Italy., Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Occhipinti MA; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Parisi A; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Porzio G; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Fargnoli MC; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; Dermatology, San Salvatore Hospital, L'Aquila, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy., Ficorella C; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Natoli C; Department of Medical, Oral & Biotechnological Sciences University G. D'Annunzio, Chieti-Pescara, Italy.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Feb 27; Vol. 7 (1), pp. 57. Date of Electronic Publication: 2019 Feb 27.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Body Mass Index*, Neoplasms/*epidemiology, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/pharmacology ; Antineoplastic Agents, Immunological/therapeutic use ; B7-H1 Antigen/antagonists & inhibitors ; Biomarkers, Tumor ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Molecular Targeted Therapy ; Neoplasm Staging ; Neoplasms/drug therapy ; Neoplasms/pathology ; Obesity/epidemiology ; Overweight/epidemiology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Proportional Hazards Models ; Treatment Outcome ; Young Adult

المؤلفون: Pistillo MP; Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. mariapia.pistillo@hsanmartino.it., Fontana V; Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Morabito A; Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy., Dozin B; Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Laurent S; Department of Internal Medicine, University of Genoa, Genoa, Italy., Carosio R; Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy., Banelli B; Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy.; Department of Health Sciences, University of Genoa, Genoa, Italy., Ferrero F; Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Spano L; Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Tanda E; Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Ferrucci PF; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Martinoli C; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.; iTeos Therapeutics, Gosselies, Belgium., Cocorocchio E; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Guida M; Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Tommasi S; Department of Medical Oncology and Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Pagani E; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Marchetti P; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.; Sapienza University of Rome, Rome, Italy., Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Fava P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Osella-Abate S; Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy., Capone M; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione'G. Pascale', Naples, Italy., Romani M; Unit of Tumor Epigenetics, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, 16132, Genoa, Italy., Spagnolo F; Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Queirolo P; Department of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

مؤلفون مشاركون: Italian Melanoma Intergroup (IMI)

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Jan; Vol. 68 (1), pp. 97-107. Date of Electronic Publication: 2018 Oct 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , CTLA-4 Antigen/*metabolism , Ipilimumab/*therapeutic use , Melanoma/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/therapeutic use ; Biomarkers, Tumor/blood ; CTLA-4 Antigen/blood ; Female ; Humans ; Italy ; Kaplan-Meier Estimate ; Male ; Melanoma/metabolism ; Melanoma/pathology ; Middle Aged ; Neoplasm Metastasis ; Predictive Value of Tests ; Solubility ; Young Adult